Mark F. McLaughlin

Gold Coated Lanthanide Phosphate Nanoparticles for Targeted Alpha Generator Radiotherapy

David J. Robertson, Jonathan S. Wall, Saed Mirzadeh, 2013, PloS one.

PSMA-Targeting Imaging and Theranostic Agents—Current Status and Future Perspective

Xiankai Sun, G. Hao, A. Pillai, 2022, International journal of molecular sciences.

Radiopharmaceutical Quality Control Considerations for Accelerator-Produced Actinium Therapies

D. Abou, D. Thorek, T. Wadas, 2022, Cancer biotherapy & radiopharmaceuticals.

LnPO4 nanoparticles doped with Ac-225 and sequestered daughters for targeted alpha therapy.

David J. Robertson, S. Kennel, S. Mirzadeh, 2014, Cancer biotherapy & radiopharmaceuticals.

Novel Indications for Commonly Used Medications as Radiation Protectants in Spaceflight.

J. Jones, D. Donoviel, Mark F. McLaughlin, 2017, Aerospace medicine and human performance.

Crossing the Blood-Brain Barrier with Antibody-Labeled, Gold-Coated Nanoconjugates: A Preliminary Step in Targeting and Eradicating Brain Tumors

Douglas C. Miller, J. D. Robertson, P. Pevsner, 2016 .

Nanoparticles and phage display selected peptides for imaging and therapy of cancer.

David J. Robertson, R. Shukla, N. Chanda, 2013, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Stereotactic body radiation therapy mitigates radiation induced lymphopenia in early stage non-small cell lung cancer

M. Baine, Chi Lin, Mark F. McLaughlin, 2020, PloS one.

Phase 2 Trial of Stereotactic Ablative Radiotherapy for Patients with Primary Renal Cancer.

Laurentiu M. Pop, J. Cadeddu, R. Hannan, 2023, European urology.